首页 > 最新文献

Cardiovascular Pathology最新文献

英文 中文
COVER 3: Editorial Board 封面 3:编辑委员会
IF 3.7 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-05-28 DOI: 10.1016/S1054-8807(24)00054-1
{"title":"COVER 3: Editorial Board","authors":"","doi":"10.1016/S1054-8807(24)00054-1","DOIUrl":"https://doi.org/10.1016/S1054-8807(24)00054-1","url":null,"abstract":"","PeriodicalId":9451,"journal":{"name":"Cardiovascular Pathology","volume":"71 ","pages":"Article 107658"},"PeriodicalIF":3.7,"publicationDate":"2024-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1054880724000541/pdfft?md5=5bd93f9aaa29a0219ba2e7932c414571&pid=1-s2.0-S1054880724000541-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141163363","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COVER 4: Table of Contents/Barcode PMS 200 封面 4:目录/条形码 PMS 200
IF 3.7 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-05-28 DOI: 10.1016/S1054-8807(24)00055-3
{"title":"COVER 4: Table of Contents/Barcode PMS 200","authors":"","doi":"10.1016/S1054-8807(24)00055-3","DOIUrl":"https://doi.org/10.1016/S1054-8807(24)00055-3","url":null,"abstract":"","PeriodicalId":9451,"journal":{"name":"Cardiovascular Pathology","volume":"71 ","pages":"Article 107659"},"PeriodicalIF":3.7,"publicationDate":"2024-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1054880724000553/pdfft?md5=e72240dcff47f60b634c951d026c4a7c&pid=1-s2.0-S1054880724000553-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141163364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Glandular cardiac myxoma with intraepithelial ductal neoplasia features: Report of the first case 具有上皮内导管瘤特征的腺性心脏肌瘤。首例报告。
IF 3.7 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-05-28 DOI: 10.1016/j.carpath.2024.107663
Eleonora Nardi , Vincenzo Arena

Cardiac myxoma are the most common primary tumor of the heart in adults. In approximately 2-5%, glandular differentiation occurs within these tumors. In the presence of glandular features attention must be taken to exclude and prevent a misdiagnosis of cardiac metastases of adenocarcinoma. Nevertheless, the localization in the left atrium, the solitary disposition of the cardiac mass, the histological features and the immunohistochemistry performed, argued against the possibility of a metastatic nature of the tumor.

We report the case of an 80-year-old woman, with a prior medical history of breast cancer, that underwent surgery for a cardiac myxoma that histologically showed glandular features.

Herein, we highlight the importance of a careful diagnosis of this entity, as it can be easily confused for a metastasis, especially in patients with a history of malignancy.

心肌瘤是成人心脏最常见的原发性肿瘤。这些肿瘤中约有 2-5% 会出现腺体分化。在出现腺体特征时,必须注意排除和防止误诊为腺癌的心脏转移。然而,左心房的定位、心脏肿块的单发性、组织学特征和免疫组化结果都表明肿瘤不可能发生转移。我们报告了一例 80 岁妇女的病例,她曾有乳腺癌病史,因心脏肌瘤接受了手术,组织学显示该肿瘤具有腺体特征。在此,我们强调对这种实体瘤进行仔细诊断的重要性,因为它很容易与转移瘤相混淆,尤其是在有恶性肿瘤病史的患者中。
{"title":"Glandular cardiac myxoma with intraepithelial ductal neoplasia features: Report of the first case","authors":"Eleonora Nardi ,&nbsp;Vincenzo Arena","doi":"10.1016/j.carpath.2024.107663","DOIUrl":"10.1016/j.carpath.2024.107663","url":null,"abstract":"<div><p>Cardiac myxoma are the most common primary tumor of the heart in adults. In approximately 2-5%, glandular differentiation occurs within these tumors. In the presence of glandular features attention must be taken to exclude and prevent a misdiagnosis of cardiac metastases of adenocarcinoma. Nevertheless, the localization in the left atrium, the solitary disposition of the cardiac mass, the histological features and the immunohistochemistry performed, argued against the possibility of a metastatic nature of the tumor.</p><p>We report the case of an 80-year-old woman, with a prior medical history of breast cancer, that underwent surgery for a cardiac myxoma that histologically showed glandular features.</p><p>Herein, we highlight the importance of a careful diagnosis of this entity, as it can be easily confused for a metastasis, especially in patients with a history of malignancy.</p></div>","PeriodicalId":9451,"journal":{"name":"Cardiovascular Pathology","volume":"72 ","pages":"Article 107663"},"PeriodicalIF":3.7,"publicationDate":"2024-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1054880724000590/pdfft?md5=4cc1c06346addedf307cd9f7064983d7&pid=1-s2.0-S1054880724000590-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141178245","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early, rapidly progressive vasculopathy in a transplanted heart: A possible complication of COVID-19 移植心脏早期快速进展性血管病变:COVID-19 可能的并发症。
IF 3.7 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-05-25 DOI: 10.1016/j.carpath.2024.107661
Bryan G. Pearson , David H. Walker , Alfred S. Lea , Wissam Khalife , Karen K. Kislingbury , Scott D. Lick , Paul J. Boor

The epidemic caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has had a significant global impact, especially on immunosuppressed populations such as heart transplant recipients. While SARS-CoV-2 initially infects the respiratory system, cardiovascular complications induced by coronavirus disease 2019 (COVID-19) include cardiac arrest, myocardial infarction, heart failure, myocarditis, arrhythmia, acute myocyte injury, thrombotic events, and cardiogenic shock. Here, we present a case of a 45-year-old African American male who tested positive for COVID-19 infection six months after receiving a heart transplant. The patient was asymptomatic initially, but two weeks later he developed dyspnea, early satiety, and abdominal bloating. The patient was admitted to the hospital for acute renal failure and subsequently diagnosed with moderate acute T cell-mediated allograft rejection (Grade 2R) by endomyocardial biopsy. Three months after testing positive for COVID-19, the patient suffered a sudden cardiac death. At autopsy, the epicardium was diffusely edematous and showed vascular congestion. The coronary arteries showed a striking concentric narrowing of lumens and diffusely thickened arterial walls of all major extramural arteries deemed consistent with a rapidly progressive form of cardiac allograft vasculopathy (CAV). SARS-CoV-2 nucleocapsid protein was localized by immunohistochemistry (IHC) in endothelial cells of venules and capillaries within the epicardium. Our localization of SARS-CoV-2 in coronary vessel endothelial cells by IHC suggests that endothelial cell infection, endotheliitis, and immune-related inflammation may be a primary mechanism of vascular injury. The present case represents an early onset rapidly progressive form of CAV. This case may be the first case of post-transplant arteriopathy occurring in such a short time that includes corresponding autopsy, surgical pathology, and IHC data.

严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)引起的流行病对全球产生了重大影响,尤其是对心脏移植受者等免疫抑制人群。虽然 SARS-CoV-2 最初感染的是呼吸系统,但 2019 年冠状病毒病(COVID-19)诱发的心血管并发症包括心脏骤停、心肌梗死、心力衰竭、心肌炎、心律失常、急性心肌细胞损伤、血栓事件和心源性休克。在此,我们介绍了一例 45 岁的非裔美国男性病例,他在接受心脏移植手术 6 个月后,COVID-19 感染检测呈阳性。患者最初并无症状,但两周后出现呼吸困难、早饱和腹胀。患者因急性肾衰竭入院,随后通过心内膜活检被诊断为中度急性T细胞介导的异体移植排斥反应(2R级)。在COVID-19检测呈阳性的三个月后,患者突发心源性猝死。尸检结果显示,患者心外膜弥漫性水肿,血管充血。冠状动脉管腔明显同心性狭窄,所有主要室外动脉壁弥漫性增厚,被认为与快速进展型心脏同种异体移植血管病(CAV)一致。通过免疫组化(IHC),SARS-CoV-2 核头状蛋白被定位在心外膜静脉和毛细血管的内皮细胞中。我们通过 IHC 在冠状动脉血管内皮细胞中定位 SARS-CoV-2 表明,内皮细胞感染、内皮炎症和免疫相关炎症可能是血管损伤的主要机制。本病例是一种早发快速进展型 CAV。本病例可能是第一例在如此短的时间内发生移植后动脉病变的病例,包括相应的尸检、手术病理和 IHC 数据。
{"title":"Early, rapidly progressive vasculopathy in a transplanted heart: A possible complication of COVID-19","authors":"Bryan G. Pearson ,&nbsp;David H. Walker ,&nbsp;Alfred S. Lea ,&nbsp;Wissam Khalife ,&nbsp;Karen K. Kislingbury ,&nbsp;Scott D. Lick ,&nbsp;Paul J. Boor","doi":"10.1016/j.carpath.2024.107661","DOIUrl":"10.1016/j.carpath.2024.107661","url":null,"abstract":"<div><p>The epidemic caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has had a significant global impact, especially on immunosuppressed populations such as heart transplant recipients. While SARS-CoV-2 initially infects the respiratory system, cardiovascular complications induced by coronavirus disease 2019 (COVID-19) include cardiac arrest, myocardial infarction, heart failure, myocarditis, arrhythmia, acute myocyte injury, thrombotic events, and cardiogenic shock. Here, we present a case of a 45-year-old African American male who tested positive for COVID-19 infection six months after receiving a heart transplant. The patient was asymptomatic initially, but two weeks later he developed dyspnea, early satiety, and abdominal bloating. The patient was admitted to the hospital for acute renal failure and subsequently diagnosed with moderate acute T cell-mediated allograft rejection (Grade 2R) by endomyocardial biopsy. Three months after testing positive for COVID-19, the patient suffered a sudden cardiac death. At autopsy, the epicardium was diffusely edematous and showed vascular congestion. The coronary arteries showed a striking concentric narrowing of lumens and diffusely thickened arterial walls of all major extramural arteries deemed consistent with a rapidly progressive form of cardiac allograft vasculopathy (CAV). SARS-CoV-2 nucleocapsid protein was localized by immunohistochemistry (IHC) in endothelial cells of venules and capillaries within the epicardium. Our localization of SARS-CoV-2 in coronary vessel endothelial cells by IHC suggests that endothelial cell infection, endotheliitis, and immune-related inflammation may be a primary mechanism of vascular injury. The present case represents an early onset rapidly progressive form of CAV. This case may be the first case of post-transplant arteriopathy occurring in such a short time that includes corresponding autopsy, surgical pathology, and IHC data.</p></div>","PeriodicalId":9451,"journal":{"name":"Cardiovascular Pathology","volume":"72 ","pages":"Article 107661"},"PeriodicalIF":3.7,"publicationDate":"2024-05-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1054880724000577/pdfft?md5=4c05cd0287d9bbfade0fdd50c91b742f&pid=1-s2.0-S1054880724000577-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141157819","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Calcification and atheroma plaques: is there any impact on the anatomical features of the aortic root and its elements? 钙化和粥样斑块:钙化和动脉粥样斑块:对主动脉根及其组成部分的解剖特征有影响吗?
IF 2.3 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-05-21 DOI: 10.1016/j.carpath.2024.107655
Kader Yılar , Buse Naz Çandır , Ceyhun Küçük , Baha Berk Arpak , Kemal Özdemir , Aysin Kale , Osman Coskun , Özcan Gayretli

Objectives

Morphometric information of the structures within the borders of the aortic root is a guide for surgical interventions. It is essential to determine the effects of aortic calcification and atheroma plaque findings on the structures of this region. This study aims to establish the normal values of aortic root structures and to investigate the impact of pathologic findings in order to guide diagnosis and treatment in the clinic.

Methods

The aortic root structures were morphometrically analyzed in fresh hearts of 110 patients (89 males, 21 females) brought to the forensic medicine institution. The distances between the bases of the aortic sinuses, their widths and heights, and the lengths of the commissures were measured to differentiate between pathologic and non-pathologic aortic classes. Parameters were compared according to gender, age, body mass index, and body surface area.

Results

The mean age was 44.71 ± 15.57 years in 21 female patients and 53.66 ± 15.67 years in 89 male patients. The results of the pathologic aorta group with calcification and atheroma plaque findings were higher than the non-pathologic aorta group in all parameters (P < .05).

Conclusions

Calcification and the presence of atheroma plaque in the aorta increase the size of the structures at the aortic root. Gender, age, body mass index, and body surface area are among the criteria that will cause changes in the structures of this region. These results will help surgeons to know the normal values of aortic root structures and to consider the effects of pathologic findings in aortic valve repair operations.

目的:主动脉根部边界内结构的形态计量信息是手术干预的指南。确定主动脉钙化和粥样斑块对该区域结构的影响至关重要。本研究旨在确定主动脉根部结构的正常值,并调查病理结果的影响,以指导临床诊断和治疗:方法:对法医机构接收的 110 名患者(89 名男性,21 名女性)的新鲜心脏的主动脉根部结构进行形态学分析。测量主动脉窦底之间的距离、宽度和高度以及瓣口的长度,以区分病理性和非病理性主动脉。根据性别、年龄、体重指数和体表面积对各项参数进行比较:结果:21 名女性患者的平均年龄为(44.71±15.57)岁,89 名男性患者的平均年龄为(53.66±15.67)岁。发现钙化和粥样斑块的病理主动脉组的所有参数结果均高于非病理主动脉组(p结论:主动脉钙化和粥样斑块的存在会增加主动脉根部结构的体积。性别、年龄、体重指数和体表面积是导致该区域结构发生变化的标准之一。这些结果将有助于外科医生了解主动脉根部结构的正常值,并在主动脉瓣修复手术中考虑病理结果的影响。
{"title":"Calcification and atheroma plaques: is there any impact on the anatomical features of the aortic root and its elements?","authors":"Kader Yılar ,&nbsp;Buse Naz Çandır ,&nbsp;Ceyhun Küçük ,&nbsp;Baha Berk Arpak ,&nbsp;Kemal Özdemir ,&nbsp;Aysin Kale ,&nbsp;Osman Coskun ,&nbsp;Özcan Gayretli","doi":"10.1016/j.carpath.2024.107655","DOIUrl":"10.1016/j.carpath.2024.107655","url":null,"abstract":"<div><h3>Objectives</h3><p>Morphometric information of the structures within the borders of the aortic root is a guide for surgical interventions. It is essential to determine the effects of aortic calcification and atheroma plaque findings on the structures of this region. This study aims to establish the normal values of aortic root structures and to investigate the impact of pathologic findings in order to guide diagnosis and treatment in the clinic.</p></div><div><h3>Methods</h3><p>The aortic root structures were morphometrically analyzed in fresh hearts of 110 patients (89 males, 21 females) brought to the forensic medicine institution. The distances between the bases of the aortic sinuses, their widths and heights, and the lengths of the commissures were measured to differentiate between pathologic and non-pathologic aortic classes. Parameters were compared according to gender, age, body mass index, and body surface area.</p></div><div><h3>Results</h3><p>The mean age was 44.71 ± 15.57 years in 21 female patients and 53.66 ± 15.67 years in 89 male patients. The results of the pathologic aorta group with calcification and atheroma plaque findings were higher than the non-pathologic aorta group in all parameters (<em>P</em> &lt; .05).</p></div><div><h3>Conclusions</h3><p>Calcification and the presence of atheroma plaque in the aorta increase the size of the structures at the aortic root. Gender, age, body mass index, and body surface area are among the criteria that will cause changes in the structures of this region. These results will help surgeons to know the normal values of aortic root structures and to consider the effects of pathologic findings in aortic valve repair operations.</p></div>","PeriodicalId":9451,"journal":{"name":"Cardiovascular Pathology","volume":"72 ","pages":"Article 107655"},"PeriodicalIF":2.3,"publicationDate":"2024-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141080790","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The natural history of CVB3 myocarditis in C57BL/6J mice: an extended in-depth characterization C57BL/6J小鼠CVB3心肌炎的自然病史:深入的扩展研究。
IF 2.3 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-05-14 DOI: 10.1016/j.carpath.2024.107652
Kasper Favere , Manon Van Hecke , Sander Eens , Matthias Bosman , Kim Stobbelaar , An Hotterbeekx , Samir Kumar-Singh , Peter L. Delputte , Erik Fransen , Johan De Sutter , Pieter-Jan Guns , Tania Roskams , Hein Heidbuchel
<div><h3>Background and aims</h3><p>Viral infections are the leading cause of myocarditis. Besides acute cardiac complications, late-stage sequelae such as myocardial fibrosis may develop, importantly impacting the prognosis. Coxsackievirus B3 (CVB)-induced myocarditis in mice is the most commonly used translational model to study viral myocarditis and has provided the majority of our current understanding of the disease pathophysiology. Nevertheless, the late stages of disease, encompassing fibrogenesis and arrhythmogenesis, have been underappreciated in viral myocarditis research to date. The present study investigated the natural history of CVB-induced myocarditis in C57BL/6J mice, expanding the focus beyond the acute phase of disease. In addition, we studied the impact of sex and inoculation dose on the disease course.</p></div><div><h3>Methods and results</h3><p>C57BL/6J mice (12 weeks old; n=154) received a single intraperitoneal injection with CVB to induce viral myocarditis, or vehicle (PBS) as control. Male mice (n=92) were injected with 5 × 10<sup>5</sup> (regular dose) (RD) or 5 × 10<sup>6</sup> (high dose) (HD) plaque-forming units of CVB, whereas female mice received the RD only. Animals were sacrificed 1, 2, 4, 8, and 11 weeks after CVB or PBS injection. Virally inoculated mice developed viral disease with a temporary decline in general condition and weight loss, which was less pronounced in female animals (<em>P</em><.001). In male CVB mice, premature mortality occurred between days 8 and 23 after inoculation (RD: 21%, HD: 20%), whereas all female animals survived. Over the course of disease, cardiac inflammation progressively subsided, with faster resolution in female mice. There were no substantial group differences in the composition of the inflammatory cell infiltrates: predominance of cytotoxic T cells at day 7 and 14, and a switch from arginase1-reactive macrophages to iNOS-reactive macrophages from day 7 to 14 were the main findings. There was concomitant development and maturation of different patterns of myocardial fibrosis, with enhanced fibrogenesis in male mice. Virus was almost completely cleared from the heart by day 14. Serum biomarkers of cardiac damage and cardiac expression of remodeling genes were temporarily elevated during the acute phase of disease. Cardiac CTGF gene upregulation was less prolonged in female CVB animals. <em>In vivo</em> electrophysiology studies at weeks 8 and 11 demonstrated that under baseline conditions (<em>i.e.</em> in the absence of proarrhythmogenic drugs), ventricular arrhythmias could only be induced in CVB animals. The cumulative arrhythmia burden throughout the entire stimulation protocol was not significantly different between CVB and control groups.</p></div><div><h3>Conclusion</h3><p>CVB inoculation in C57BL/6J mice represents a model of acute self-limiting viral myocarditis, with progression to different patterns of myocardial fibrosis. Sex, but not inoculation dose, seems t
背景和目的:病毒感染是心肌炎的主要病因。除急性心脏并发症外,还可能出现心肌纤维化等晚期后遗症,对预后产生重要影响。柯萨奇病毒 B3(CVB)诱导的小鼠心肌炎是研究病毒性心肌炎最常用的转化模型,它为我们提供了目前对该疾病病理生理学的大部分认识。然而,在病毒性心肌炎的研究中,包括纤维形成和心律失常在内的疾病晚期阶段至今仍未得到足够重视。本研究调查了 CVB 诱导的 C57BL/6J 小鼠心肌炎的自然史,将研究重点扩展到疾病的急性期之外。此外,我们还研究了性别和接种剂量对病程的影响:C57BL/6J小鼠(12周大;n=154)腹腔注射一次CVB诱导病毒性心肌炎,或以载体(PBS)作为对照。雄性小鼠(n=92)注射 5 × 105(常规剂量)(RD)或 5 × 106(高剂量)(HD)斑块形成单位的 CVB,而雌性小鼠只注射 RD。动物在注射 CVB 或 PBS 1、2、4、8 和 11 周后被处死。接种病毒的小鼠出现病毒性疾病,全身状况暂时性下降,体重减轻,雌性小鼠的症状不明显(PC结论:接种CVB的C57小鼠和接种RD的雌性小鼠均出现病毒性疾病:C57BL/6J小鼠接种CVB代表了一种急性自限性病毒性心肌炎模型,其心肌纤维化的发展模式各不相同。性别(而非接种剂量)似乎能调节疾病的进程。
{"title":"The natural history of CVB3 myocarditis in C57BL/6J mice: an extended in-depth characterization","authors":"Kasper Favere ,&nbsp;Manon Van Hecke ,&nbsp;Sander Eens ,&nbsp;Matthias Bosman ,&nbsp;Kim Stobbelaar ,&nbsp;An Hotterbeekx ,&nbsp;Samir Kumar-Singh ,&nbsp;Peter L. Delputte ,&nbsp;Erik Fransen ,&nbsp;Johan De Sutter ,&nbsp;Pieter-Jan Guns ,&nbsp;Tania Roskams ,&nbsp;Hein Heidbuchel","doi":"10.1016/j.carpath.2024.107652","DOIUrl":"10.1016/j.carpath.2024.107652","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Background and aims&lt;/h3&gt;&lt;p&gt;Viral infections are the leading cause of myocarditis. Besides acute cardiac complications, late-stage sequelae such as myocardial fibrosis may develop, importantly impacting the prognosis. Coxsackievirus B3 (CVB)-induced myocarditis in mice is the most commonly used translational model to study viral myocarditis and has provided the majority of our current understanding of the disease pathophysiology. Nevertheless, the late stages of disease, encompassing fibrogenesis and arrhythmogenesis, have been underappreciated in viral myocarditis research to date. The present study investigated the natural history of CVB-induced myocarditis in C57BL/6J mice, expanding the focus beyond the acute phase of disease. In addition, we studied the impact of sex and inoculation dose on the disease course.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Methods and results&lt;/h3&gt;&lt;p&gt;C57BL/6J mice (12 weeks old; n=154) received a single intraperitoneal injection with CVB to induce viral myocarditis, or vehicle (PBS) as control. Male mice (n=92) were injected with 5 × 10&lt;sup&gt;5&lt;/sup&gt; (regular dose) (RD) or 5 × 10&lt;sup&gt;6&lt;/sup&gt; (high dose) (HD) plaque-forming units of CVB, whereas female mice received the RD only. Animals were sacrificed 1, 2, 4, 8, and 11 weeks after CVB or PBS injection. Virally inoculated mice developed viral disease with a temporary decline in general condition and weight loss, which was less pronounced in female animals (&lt;em&gt;P&lt;/em&gt;&lt;.001). In male CVB mice, premature mortality occurred between days 8 and 23 after inoculation (RD: 21%, HD: 20%), whereas all female animals survived. Over the course of disease, cardiac inflammation progressively subsided, with faster resolution in female mice. There were no substantial group differences in the composition of the inflammatory cell infiltrates: predominance of cytotoxic T cells at day 7 and 14, and a switch from arginase1-reactive macrophages to iNOS-reactive macrophages from day 7 to 14 were the main findings. There was concomitant development and maturation of different patterns of myocardial fibrosis, with enhanced fibrogenesis in male mice. Virus was almost completely cleared from the heart by day 14. Serum biomarkers of cardiac damage and cardiac expression of remodeling genes were temporarily elevated during the acute phase of disease. Cardiac CTGF gene upregulation was less prolonged in female CVB animals. &lt;em&gt;In vivo&lt;/em&gt; electrophysiology studies at weeks 8 and 11 demonstrated that under baseline conditions (&lt;em&gt;i.e.&lt;/em&gt; in the absence of proarrhythmogenic drugs), ventricular arrhythmias could only be induced in CVB animals. The cumulative arrhythmia burden throughout the entire stimulation protocol was not significantly different between CVB and control groups.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusion&lt;/h3&gt;&lt;p&gt;CVB inoculation in C57BL/6J mice represents a model of acute self-limiting viral myocarditis, with progression to different patterns of myocardial fibrosis. Sex, but not inoculation dose, seems t","PeriodicalId":9451,"journal":{"name":"Cardiovascular Pathology","volume":"72 ","pages":"Article 107652"},"PeriodicalIF":2.3,"publicationDate":"2024-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1054880724000486/pdfft?md5=9abb2fe6eb6fe235fd9c688088a30ead&pid=1-s2.0-S1054880724000486-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140944094","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The mitochondrial uncoupler 2,4-dinitrophenol modulates inflammatory and oxidative responses in Trypanosoma cruzi-induced acute myocarditis in mice 线粒体解偶联剂 2,4-二硝基苯酚可调节克鲁兹锥虫诱发的小鼠急性心肌炎的炎症和氧化反应。
IF 3.7 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-05-11 DOI: 10.1016/j.carpath.2024.107653
José Edson Caetano-da-Silva , Elda Gonçalves-Santos , Elisa L.B.C. Domingues , Ivo S. Caldas , Graziela D.A. Lima , Lívia F. Diniz , Reggiani V. Gonçalves , Rômulo D. Novaes

By uncoupling oxidative phosphorylation, 2,4-dinitrophenol (DNP) attenuates reactive oxygen species (ROS) biosynthesis, which are known to aggravate infectious myocarditis in Chagas disease. Thus, the impact of DNP-based chemotherapy on Trypanosoma cruzi-induced acute myocarditis was investigated. C56BL/6 mice uninfected and infected untreated and treated daily with 100 mg/kg benznidazole (Bz, reference drug), 5 and 10 mg/kg DNP by gavage for 11 days after confirmation of T. cruzi infection were investigated. Twenty-four hours ​after the last treatment, the animals were euthanized and the heart was collected for microstructural, immunological and biochemical analyses. T. cruzi inoculation induced systemic inflammation (e.g., cytokines and anti-T. cruzi IgG upregulation), cardiac infection (T. cruzi DNA), oxidative stress, inflammatory infiltrate and microstructural myocardial damage in untreated mice. DNP treatment aggravated heart infection and microstructural damage, which were markedly attenuated by Bz. DNP (10 mg/kg) was also effective in attenuating ROS (total ROS, H2O2, and O2), nitric oxide (NO), lipid (malondialdehyde - MDA) and protein (protein carbonyl - PCn) oxidation, TNF, IFN-γ, IL-10, and MCP-1/CCL2, anti-T. cruzi IgG, cardiac troponin I levels, as well as inflammatory infiltrate and cardiac damage in T. cruzi-infected mice. Our findings indicate that DNP aggravated heart infection and microstructural cardiomyocytes damage in infected mice. These responses were related to the antioxidant and anti-inflammatory properties of DNP, which favors infection by weakening the pro-oxidant and pro-inflammatory protective mechanisms of the infected host. Conversely, Bz-induced cardioprotective effects combined effective anti-inflammatory and antiparasitic responses, which protect against heart infection, oxidative stress, and microstructural damage in Chagas disease.

2,4-二硝基苯酚(DNP)通过解偶联氧化磷酸化,可抑制活性氧(ROS)的生物合成,而众所周知,活性氧会加重南美锥虫病感染性心肌炎的病情。因此,我们研究了基于 DNP 的化疗对克鲁兹锥虫诱发的急性心肌炎的影响。研究人员对未感染和感染的 C56BL/6 小鼠进行了调查,这些小鼠在确认感染 T. cruzi 后,每天灌胃 100 毫克/千克苯并咪唑(Bz,参考药物)、5 毫克/千克和 10 毫克/千克 DNP,连续 11 天。最后一次治疗 24 小时后,动物被安乐死,收集心脏进行显微结构、免疫学和生化分析。在未经处理的小鼠中,接种 T. cruzi 会诱发全身炎症(如细胞因子和抗 T. cruzi IgG 上调)、心脏感染(T. cruzi DNA)、氧化应激、炎症浸润和心肌微结构损伤。DNP 处理会加重心脏感染和微结构损伤,而 Bz 则会明显减轻这些损伤。DNP(10 毫克/千克)还能有效减轻 ROS(总 ROS、H2O2 和 O2-)、一氧化氮(NO)、脂质(丙二醛 - MDA)和蛋白质(蛋白质羰基 - PCn)氧化、TNF、IFN-γ、IL-10 和 MCP-1/CCL2、抗 T. cruzi IgG、心肌肌钙蛋白 I 水平,以及 T. cruzi 感染小鼠的炎症浸润和心脏损伤。我们的研究结果表明,DNP 会加重感染小鼠的心脏感染和心肌细胞微结构损伤。这些反应与 DNP 的抗氧化和抗炎特性有关,DNP 会削弱感染宿主的促氧化和促炎症保护机制,从而有利于感染。相反,Bz诱导的心脏保护作用结合了有效的抗炎和抗寄生虫反应,可防止恰加斯病的心脏感染、氧化应激和微结构损伤。
{"title":"The mitochondrial uncoupler 2,4-dinitrophenol modulates inflammatory and oxidative responses in Trypanosoma cruzi-induced acute myocarditis in mice","authors":"José Edson Caetano-da-Silva ,&nbsp;Elda Gonçalves-Santos ,&nbsp;Elisa L.B.C. Domingues ,&nbsp;Ivo S. Caldas ,&nbsp;Graziela D.A. Lima ,&nbsp;Lívia F. Diniz ,&nbsp;Reggiani V. Gonçalves ,&nbsp;Rômulo D. Novaes","doi":"10.1016/j.carpath.2024.107653","DOIUrl":"10.1016/j.carpath.2024.107653","url":null,"abstract":"<div><p>By uncoupling oxidative phosphorylation, 2,4-dinitrophenol (DNP) attenuates reactive oxygen species (ROS) biosynthesis, which are known to aggravate infectious myocarditis in Chagas disease. Thus, the impact of DNP-based chemotherapy on <em>Trypanosoma cruzi</em>-induced acute myocarditis was investigated. C56BL/6 mice uninfected and infected untreated and treated daily with 100 mg/kg benznidazole (Bz, reference drug), 5 and 10 mg/kg DNP by gavage for 11 days after confirmation of <em>T. cruzi</em> infection were investigated. Twenty-four hours ​after the last treatment, the animals were euthanized and the heart was collected for microstructural, immunological and biochemical analyses. <em>T. cruzi</em> inoculation induced systemic inflammation (e.g., cytokines and anti-<em>T. cruzi</em> IgG upregulation), cardiac infection (<em>T. cruzi</em> DNA), oxidative stress, inflammatory infiltrate and microstructural myocardial damage in untreated mice. DNP treatment aggravated heart infection and microstructural damage, which were markedly attenuated by Bz. DNP (10 mg/kg) was also effective in attenuating ROS (total ROS, H<sub>2</sub>O<sub>2</sub>, and O<sub>2</sub><sup>−</sup>), nitric oxide (NO), lipid (malondialdehyde - MDA) and protein (protein carbonyl - PCn) oxidation, TNF, IFN-γ, IL-10, and MCP-1/CCL2, anti-<em>T. cruzi</em> IgG, cardiac troponin I levels, as well as inflammatory infiltrate and cardiac damage in <em>T. cruzi-</em>infected mice. Our findings indicate that DNP aggravated heart infection and microstructural cardiomyocytes damage in infected mice. These responses were related to the antioxidant and anti-inflammatory properties of DNP, which favors infection by weakening the pro-oxidant and pro-inflammatory protective mechanisms of the infected host. Conversely, Bz-induced cardioprotective effects combined effective anti-inflammatory and antiparasitic responses, which protect against heart infection, oxidative stress, and microstructural damage in Chagas disease.</p></div>","PeriodicalId":9451,"journal":{"name":"Cardiovascular Pathology","volume":"72 ","pages":"Article 107653"},"PeriodicalIF":3.7,"publicationDate":"2024-05-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140915908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The cardiovascular pathologist in the aortic team 主动脉团队中的心血管病理学家。
IF 3.7 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-05-03 DOI: 10.1016/j.carpath.2024.107649
Angela Pucci , Martina Rossetti , Chiara Lenzi , Maximilian L Buja

Aortic diseases require a multidisciplinary management for diagnosis, treatment and follow-up with better outcomes in referral centers using a team-based approach. The setting up of a multi-disciplinary aortic team for the discussion of complex cases has been already proposed; it is also supported by the ACC/AHA. Surgeons and radiologists, more or less other physicians such as cardiologists, geneticists, rheumatologists/internal medicine specialists and pathologists are involved into such a team. The role of the cardiovascular pathologist is to examine the aortic specimens, to diagnose and classify the aortic lesions. Herein, the role of the pathologist in the aortic team is discussed and the pathobiology of aortic diseases is reviewed for reference by pathologists. The aortic specimens are mainly obtained from emergency or elective surgical procedures on the thoracic aorta, less frequently from organ/tissue (including cardiac or heart valve) donors, post-mortem procedures or abdominal aortic surgery. In the last decade, together with the progress of medical sciences, the histological definitions and classifications of the aortic pathology are undergoing thorough revisions that are addressed to an etiopathogenetic approach because of possible clinico-pathological correlations, therapeutic and prognostic impact. Pathologists may also have an important role in research and teaching. Therefore, histological analyses of the aortic specimens require adequate sample processing and pathologist expertise because histology contributes to definite diagnosis, correct management of patients and even (in genetic diseases) families, but also to research in the challenging field of aortopathies.

主动脉疾病的诊断、治疗和随访需要多学科的管理,转诊中心采用团队合作的方法可以取得更好的疗效。成立多学科主动脉小组讨论复杂病例的建议已经提出,并得到了 ACC/AHA 的支持。外科医生和放射科医生以及心脏病专家、遗传学家、风湿病专家/内科专家和病理学家等其他医生或多或少都会参与到这样的团队中。心血管病理学家的职责是检查主动脉标本,对主动脉病变进行诊断和分类。本文将讨论病理学家在主动脉团队中的作用,并回顾主动脉疾病的病理生物学,供病理学家参考。主动脉标本主要来自胸主动脉的急诊或择期手术,较少来自器官/组织(包括心脏或心脏瓣膜)捐献者、死后手术或腹主动脉手术。近十年来,随着医学科学的进步,主动脉病理学的组织学定义和分类正在进行彻底的修订,由于可能存在的临床病理学相关性、治疗和预后影响,这些定义和分类都是针对病因学方法的。病理学家也可以在研究和教学中发挥重要作用。因此,主动脉标本的组织学分析需要充分的样本处理和病理学家的专业知识,因为组织学有助于明确诊断、正确管理患者甚至(遗传性疾病)家庭,同时也有助于在具有挑战性的主动脉疾病领域开展研究。
{"title":"The cardiovascular pathologist in the aortic team","authors":"Angela Pucci ,&nbsp;Martina Rossetti ,&nbsp;Chiara Lenzi ,&nbsp;Maximilian L Buja","doi":"10.1016/j.carpath.2024.107649","DOIUrl":"10.1016/j.carpath.2024.107649","url":null,"abstract":"<div><p>Aortic diseases require a multidisciplinary management for diagnosis, treatment and follow-up with better outcomes in referral centers using a team-based approach. The setting up of a multi-disciplinary aortic team for the discussion of complex cases has been already proposed; it is also supported by the ACC/AHA. Surgeons and radiologists, more or less other physicians such as cardiologists, geneticists, rheumatologists/internal medicine specialists and pathologists are involved into such a team. The role of the cardiovascular pathologist is to examine the aortic specimens, to diagnose and classify the aortic lesions. Herein, the role of the pathologist in the aortic team is discussed and the pathobiology of aortic diseases is reviewed for reference by pathologists. The aortic specimens are mainly obtained from emergency or elective surgical procedures on the thoracic aorta, less frequently from organ/tissue (including cardiac or heart valve) donors, <em>post-mortem</em> procedures or abdominal aortic surgery. In the last decade, together with the progress of medical sciences, the histological definitions and classifications of the aortic pathology are undergoing thorough revisions that are addressed to an etiopathogenetic approach because of possible clinico-pathological correlations, therapeutic and prognostic impact. Pathologists may also have an important role in research and teaching. Therefore, histological analyses of the aortic specimens require adequate sample processing and pathologist expertise because histology contributes to definite diagnosis, correct management of patients and even (in genetic diseases) families, but also to research in the challenging field of aortopathies.</p></div>","PeriodicalId":9451,"journal":{"name":"Cardiovascular Pathology","volume":"72 ","pages":"Article 107649"},"PeriodicalIF":3.7,"publicationDate":"2024-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140859840","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COVER 4: Table of Contents/Barcode PMS 200 封面 4:目录/条形码 PMS 200
IF 3.7 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-05-01 DOI: 10.1016/S1054-8807(24)00041-3
{"title":"COVER 4: Table of Contents/Barcode PMS 200","authors":"","doi":"10.1016/S1054-8807(24)00041-3","DOIUrl":"https://doi.org/10.1016/S1054-8807(24)00041-3","url":null,"abstract":"","PeriodicalId":9451,"journal":{"name":"Cardiovascular Pathology","volume":"70 ","pages":"Article 107645"},"PeriodicalIF":3.7,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1054880724000413/pdfft?md5=2923156c443ab31366481a9017f6353b&pid=1-s2.0-S1054880724000413-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140844316","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COVER 3: Editorial Board 封面 3:编辑委员会
IF 3.7 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-05-01 DOI: 10.1016/S1054-8807(24)00040-1
{"title":"COVER 3: Editorial Board","authors":"","doi":"10.1016/S1054-8807(24)00040-1","DOIUrl":"https://doi.org/10.1016/S1054-8807(24)00040-1","url":null,"abstract":"","PeriodicalId":9451,"journal":{"name":"Cardiovascular Pathology","volume":"70 ","pages":"Article 107644"},"PeriodicalIF":3.7,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1054880724000401/pdfft?md5=07ef87131caa97e65882b52c7adef024&pid=1-s2.0-S1054880724000401-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140844315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Cardiovascular Pathology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1